What are the risk factors for psoriasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Psoriasis

Smoking, obesity, family history, and alcohol consumption are the strongest modifiable and non-modifiable risk factors for developing psoriasis, with behavioral factors like stress and environmental tobacco smoke exposure also playing significant roles.

Non-Modifiable Risk Factors

Genetic Predisposition

  • Family history of psoriasis is the single strongest risk factor, with an odds ratio of 33.96 (95% CI = 14.14-81.57), indicating individuals with affected family members have a 34-fold increased risk 1
  • The genetic effect is stronger in men (OR = 30.39) than women (OR = 16.99) 1
  • Strong linkage to HLA-Cw6 and DR7 exists in early-onset disease, though concordance in monozygotic twins is only 67%, emphasizing the critical role of environmental triggers 2

Modifiable Behavioral Risk Factors

Smoking

  • Both active smoking and environmental tobacco smoke exposure significantly increase psoriasis risk 3
  • In the Utah Psoriasis Initiative database of over 800 subjects, 37% of psoriatics smoke versus 13% in the general population (p<0.001) 3
  • Critically, 78% of psoriasis patients started smoking before disease onset versus only 22% after, suggesting smoking is a true risk factor rather than a consequence 3
  • Past and current smoking is associated with psoriasis development in women according to the Nurses Health Study II 3
  • Smoking is strongly associated with pustular psoriasis specifically 3
  • Environmental tobacco smoke exposure at home increases risk (OR = 2.29; 95% CI = 1.12-4.67), with the effect particularly pronounced in women (OR = 2.44) 1

Obesity and Weight

  • Obesity (BMI ≥30) is both a risk factor for developing psoriasis and associated with more severe disease 3
  • In the Nurses Health Study II, increased adiposity and weight gain were strong risk factors for psoriasis development in women 3
  • Psoriasis patients have significantly higher BMI compared to controls, with severe psoriasis associated with higher BMI than mild psoriasis 3
  • The mean weight of patients entering psoriasis clinical trials frequently exceeds 90 kg 3
  • Weight loss from gastric bypass surgery has resulted in psoriasis remission in case studies, suggesting the relationship may be reversible 3

Alcohol Consumption

  • Alcohol use is an independent risk factor for psoriasis with an odds ratio of 2.55 (95% CI = 1.26-5.17) 1
  • A positive dose-response relationship exists between alcohol intake and psoriasis severity, particularly in women 3
  • Higher pretreatment daily alcohol consumption is associated with less treatment-induced improvement in men 3
  • Higher mortality from alcohol-related disease is seen in patients hospitalized for moderate to severe psoriasis 3

Psychosocial Stress

  • Stressful life events, particularly changes in work conditions, significantly increase psoriasis risk (OR = 8.34; 95% CI = 1.86-37.43) 1
  • Emotional stress is consistently reported as a trigger for psoriasis exacerbations 2, 4
  • Divorce status is associated with increased risk (OR = 5.69; 95% CI = 2.26-14.34), likely reflecting chronic stress 1

Physical Activity

  • Sedentary lifestyle contributes to psoriasis risk 5, 4
  • The National Psoriasis Foundation recommends exercising 3 times weekly for 30 minutes or more as a protective measure 3, 6

Environmental and Infectious Triggers

Infections

  • Upper respiratory infections are reported triggers for psoriasis, particularly guttate psoriasis 2
  • Streptococcal infections classically precipitate guttate psoriasis in genetically predisposed individuals 7

Trauma

  • Physical skin trauma (Koebner phenomenon) can trigger psoriasis lesions in predisposed individuals 7, 2

Geographic and Social Factors

  • Urban dwelling increases risk (OR = 3.61; 95% CI = 0.99-13.18) compared to rural living 1

Drug-Induced Psoriasis Risk Factors

High-Risk Medications

  • Beta-blockers have strong evidence for causing or exacerbating psoriasis 8
  • Lithium is strongly associated with psoriasis induction and exacerbation 8
  • Synthetic antimalarial drugs (chloroquine, hydroxychloroquine) can trigger psoriasis 8
  • NSAIDs and tetracyclines are occasionally reported to aggravate psoriasis 8

Associated Comorbidities as Risk Indicators

Metabolic and Cardiovascular

  • Metabolic syndrome is independently associated with psoriasis regardless of disease severity 3
  • Psoriasis patients have higher frequencies of hyperlipidemia, hypertension, insulin resistance, diabetes mellitus, and homocysteinemia 3
  • The chronic inflammatory nature of psoriasis itself may be an independent risk factor for cardiovascular disease and myocardial infarction 3

Depression

  • Depression prevalence in psoriasis patients is approximately 24%, which may compound cardiovascular risk 3
  • Lack of self-esteem and mood disorders are more prevalent in psoriasis patients 3

Critical Clinical Pitfalls

  • Do not assume smoking or obesity developed after psoriasis onset—the majority of behavioral risk factors precede disease development and represent true causal relationships 3
  • Screen for family history carefully, as it represents the strongest single risk factor and should guide counseling about disease likelihood in relatives 1
  • Review medication lists systematically for beta-blockers, lithium, and antimalarials in patients with new-onset or worsening psoriasis 8
  • Recognize that cardiovascular risk factors cluster in psoriasis patients, requiring comprehensive screening starting at age 20 with intensified monitoring by age 40 3

References

Research

Risk factors for psoriasis: A case-control study.

The Journal of dermatology, 2009

Research

Epidemiology of psoriasis: clinical issues.

The Journal of investigative dermatology, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiovascular Risk Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Plaque Psoriasis with Heart Failure and Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Psoriasis: Recognition and Management Strategies.

American family physician, 2023

Research

Drug-induced psoriasis. Recognition and management.

American journal of clinical dermatology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.